Vimarsana
Biggest News Aggregation in the World

Page 19 - Zymeworks Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zymeworks Inc Today - Breaking & Trending Today

JAZZ Stock Price | Jazz Pharmaceuticals PLC Stock Quote (U.S.: Nasdaq) - Vimarsana News

JAZZ Stock Price | Jazz Pharmaceuticals PLC Stock Quote (U.S.: Nasdaq)

JAZZ | Complete Jazz Pharmaceuticals PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

10 Undervalued Canadian Stocks To Invest In - Vimarsana News

10 Undervalued Canadian Stocks To Invest In

In this piece, we will take a look at ten undervalued Canadian stocks to invest in. If you want to skip our take on the Canadian economy, then head on over to 5 Undervalued Canadian Stocks To Invest In. Canada is one of the largest economies in the world, with estimates from the International Monetary […]

Source: yahoo.com
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Zymeworks Inc. (NYSE:ZYME) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Zymeworks Inc. (NYSE:ZYME – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among […]

Zymeworks Inc. (NYSE:ZYME) Receives $12.44 Average Price Target from Brokerages - Vimarsana News

Zymeworks Inc. (NYSE:ZYME) Receives $12.44 Average Price Target from Brokerages

Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price […]

Source: wkrb13.com
Zymeworks Announces Participation in Upcoming Investor Conference - Vimarsana News

Zymeworks Announces Participation in Upcoming Investor Conference

VANCOUVER, British Columbia, July 03, 2023 -- Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will...